PainNCT03098212
Aromatherapy for Reducing Labor Pain
A study testing Aromatherapy in people with Pain, run by Chiang Mai University.
Trial summary
Pregnant women who eligible with inclusion criteria are random to two groups. Aromatherapy group will receive the aromatherapy during labor along with standard pain control. Non-aromatherapy group will receive standard pain control during labor Read more about this study
- Who is it for?
- Any age, women only
- Conditions the study is for
- Pain
- What is being tested?
- Aromatherapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 94 participants
- Where
- No sites listed yet
- Study dates
- Mar 2015to Dec 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Singleton pregnancy
- Nulliparous
- 37 complete weeks of gestation
- Cephalic presentation
- No emergency obstetric complication
- In labor
Who cannot join
- Medical or obstetric complication preclude vaginal delivery
- Essential oil allergy
- Side effect of aromatherapy
About this study
Official title: Efficacy of Aromatherapy for Reducing Pain During Labor
Pregnant women who eligible with inclusion criteria are random to two groups. Aromatherapy group will receive the aromatherapy during labor along with standard pain control.
Non-aromatherapy group will receive standard pain control during labor
- Conditions
- Pain
- Being tested
- Aromatherapy
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AromatherapyOther
On the day of admission for labor. Pregnant women select type of essential oil. Aroma diffuser is used during labor. Pain score was record during latent, early active and late active phase.
| Study group | Role | What they receive |
|---|---|---|
| Aromatherapy | Experimental | Receive essential oil diffuse by Aroma diffuser during labor. Pain score and dose of analgesics drug are recorded Receives: Other: Aromatherapy |
| Non-aromatherapy | No intervention | This group receive pain control by standard of care without essential oil (aromatherapy) |
What is being measured
The primary outcome is the main question the study is designed to answer.
early active phase pain using Visual Analog Scale
Visual analog scale used to assess pain during cervical dilate 5-7 cm.
Measured: The day of labor
Secondary outcomes (3)
latent phase pain using Visual Analog Scale
Visual analog scale used to assess pain during cervical dilate 3-4 cm.
Measured: The day of labor
late active phase pain using Visual Analog Scale
Visual analog scale used to assess pain during cervical dilate 8-10 cm.
Measured: The day of labor
analgesic drug
doses of analgesic drug request by pregnant women
Measured: The day of labor
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Mar 2017
- Study startMar 2015
- Primary completionDec 2016
- Study completionDec 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 94 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chiang Mai University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kuntharee Traisrisilp, Chiang Mai University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03098212
- Sponsor's protocol ID
- 3487
- Status last verified
- Mar 2026
- First submitted
- 8 Mar 2017
- Last updated
- 18 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Aromatherapy for Reducing Pain During Labor
- ClinicalTrials.gov ID
- NCT03098212
- Acronym / sponsor ID
- 3487
- Conditions
- Pain
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 94 participants (actual)
- Lead sponsor
- Chiang Mai UniversityUniversity, hospital or other
- Study start
- Mar 2015 (actual)
- Primary completion
- Dec 2016 (actual)
- Study completion
- Dec 2016 (actual)
- First posted
- 31 Mar 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pregnant women who eligible with inclusion criteria are random to two groups. Aromatherapy group will receive the aromatherapy during labor along with standard pain control.
Non-aromatherapy group will receive standard pain control during labor
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Aromatherapy | Experimental | Other: AromatherapyReceive essential oil diffuse by Aroma diffuser during labor. Pain score and dose of analgesics drug are recorded |
| Non-aromatherapy | No intervention | –This group receive pain control by standard of care without essential oil (aromatherapy) |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (6 listed)
- Singleton pregnancy
- Nulliparous
- 37 complete weeks of gestation
- Cephalic presentation
- No emergency obstetric complication
Key exclusion criteria (3 listed)
- Medical or obstetric complication preclude vaginal delivery
- Essential oil allergy
- Side effect of aromatherapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AromatherapyOn the day of admission for labor. Pregnant women select type of essential oil. Aroma diffuser is used during labor. Pain score was record during latent, early active and late active phase. | Other | Aromatherapy |
Primary outcome
early active phase pain using Visual Analog Scale
Time frame: The day of labor
Visual analog scale used to assess pain during cervical dilate 5-7 cm.
3 secondary outcomes
latent phase pain using Visual Analog Scale
Time frame: The day of labor
late active phase pain using Visual Analog Scale
Time frame: The day of labor
analgesic drug
Time frame: The day of labor
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Pain
Recruiting
Conventional and Nano-Metronidazole Irrigation With/Without Activation in Necrotic Teeth With Apical Periodontitis
Pulp Necrosis, Apical Periodontitis
Not yet recruiting
The Mechanism Underlying the Analgesic Effect of the Music of IBS Pain
Abdominal Pain/ Discomfort, Irritable Bowel Syndrome
RecruitingPhase 4
Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures
Opioid Use, Fractures, Bone
Enrolling by invitation
Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery
Pain Catastrophizing, Pain, Chronic
Not yet recruiting
Multicomponent Exercise and Pain Science Education for Fall Prevention in Older Adults With Chronic Musculoskeletal Pain (MovePainFall)
Chronic Pain, Musculoskeletal Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Aromatherapy in people with Pain, run by Chiang Mai University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
early active phase pain using Visual Analog Scale (time frame: The day of labor). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.